|
US5501969A
(en)
|
1994-03-08 |
1996-03-26 |
Human Genome Sciences, Inc. |
Human osteoclast-derived cathepsin
|
|
IL117175A
(en)
*
|
1995-02-20 |
2005-11-20 |
Sankyo Co |
Osteoclastogenesis inhibitory factor protein
|
|
HUP9802488A3
(en)
*
|
1995-10-30 |
2001-10-29 |
Smithkline Beecham Corp |
Method of inhibiting cathepsin k
|
|
SK56798A3
(en)
*
|
1995-10-30 |
1998-12-02 |
Smithkline Beecham Corp |
Protease inhibitors, pharmaceutical composition containing them and their use
|
|
US6586466B2
(en)
|
1995-10-30 |
2003-07-01 |
Smithkline Beecham Corporation |
Carbohydrazide-protease inhibitors
|
|
WO1999015691A1
(en)
*
|
1997-09-24 |
1999-04-01 |
Snow Brand Milk Products Co., Ltd. |
Method for diagnosing bone dysbolism
|
|
US20030144175A1
(en)
*
|
1998-12-23 |
2003-07-31 |
Smithkline Beecham Corporation |
Protease inhibitors
|
|
US20030044399A1
(en)
*
|
1998-12-23 |
2003-03-06 |
Smithkline Beecham Corporation |
Method of treatment
|
|
WO2000061785A2
(en)
*
|
1999-04-14 |
2000-10-19 |
Smithkline Beecham Corporation |
Polynucleotide and polypeptide sequences of monkey cathepsin k
|
|
US20040214889A1
(en)
*
|
1999-07-31 |
2004-10-28 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
|
US6537785B1
(en)
|
1999-09-14 |
2003-03-25 |
Genzyme Glycobiology Research Institute, Inc. |
Methods of treating lysosomal storage diseases
|
|
US6770468B1
(en)
|
1999-09-14 |
2004-08-03 |
Genzyme Glycobiology Research Institute, Inc. |
Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
|
|
US6583137B1
(en)
|
1999-11-10 |
2003-06-24 |
Smithkline Beecham Corporation |
Protease inhibitors
|
|
JP2003513971A
(ja)
|
1999-11-10 |
2003-04-15 |
スミスクライン・ビーチャム・コーポレイション |
プロテア−ゼ阻害剤
|
|
EP1229914A4
(en)
|
1999-11-10 |
2004-06-23 |
Smithkline Beecham Corp |
PROTEASE INHIBITORS
|
|
JP2001158736A
(ja)
*
|
1999-11-30 |
2001-06-12 |
Snow Brand Milk Prod Co Ltd |
骨関節疾患の予防及び改善剤
|
|
ATE444086T1
(de)
*
|
1999-12-07 |
2009-10-15 |
Univ Rutgers |
Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
|
|
KR20020082896A
(ko)
*
|
2000-03-21 |
2002-10-31 |
스미스클라인 비참 코포레이션 |
프로테아제 억제제
|
|
WO2001098318A1
(en)
*
|
2000-06-22 |
2001-12-27 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the slc26a2 gene
|
|
US20070105841A1
(en)
*
|
2000-08-14 |
2007-05-10 |
Breitenbucher J G |
Method for treating allergies using substituted pyrazoles
|
|
HK1052509B
(en)
*
|
2000-08-14 |
2007-09-07 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrazole
|
|
US7332494B2
(en)
*
|
2000-08-14 |
2008-02-19 |
Janssen Pharmaceutica, N.V. |
Method for treating allergies using substituted pyrazoles
|
|
MXPA03001960A
(es)
*
|
2000-09-06 |
2004-03-18 |
Johnson & Johnson |
Un metodo para tratar alergias.
|
|
US20030073672A1
(en)
*
|
2001-09-05 |
2003-04-17 |
Breitenbucher J. Guy |
Method for treating allergies using substituted pyrazoles
|
|
WO2003041635A2
(en)
*
|
2001-09-24 |
2003-05-22 |
Mount Sinai School Of Medicine |
Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
|
|
US6800472B2
(en)
|
2001-12-21 |
2004-10-05 |
Genzyme Glycobiology Research Institute, Inc. |
Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
|
|
US6905856B2
(en)
|
2001-12-21 |
2005-06-14 |
Genzyme Glycobiology Research Institute, Inc. |
Soluble GlcNAc phosphotransferase
|
|
US20040138162A1
(en)
*
|
2002-08-30 |
2004-07-15 |
Roodman G. David |
Method of resisting osteoclast formation
|
|
US20040170621A1
(en)
*
|
2002-08-30 |
2004-09-02 |
Roodman G. David |
Method of resisting osteoclast formation
|
|
EP1990346A3
(en)
*
|
2002-12-09 |
2009-02-18 |
ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA acting for and on behalf of ARIZONA STATE UNIVERSITY |
Process for the preparation of narcistatin prodrugs
|
|
WO2004058238A1
(en)
*
|
2002-12-23 |
2004-07-15 |
Alcon, Inc. |
Use of cathepsin k inhibitors for the treatment of glaucoma
|
|
WO2005089736A2
(en)
*
|
2004-03-05 |
2005-09-29 |
The Arizona Board Of Regents, On Behalf Of, Arizona State University |
Methods for treating inflammatory and autoimmune diseases
|
|
WO2009076490A1
(en)
*
|
2007-12-12 |
2009-06-18 |
Velcura Therapeutics, Inc. |
Use of cathepsin l antagonists in the treatment of bone disease
|
|
CA3169831C
(en)
*
|
2009-10-30 |
2025-11-18 |
Sapienza Universita Di Roma |
Pluripodent Stem Cells from the Extrahepatic Biliary Tree and Methods for Their Isolation
|
|
WO2013037770A1
(en)
*
|
2011-09-15 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Method for the continuous production of water-dispersible vinyl polymers
|
|
CN112251436A
(zh)
|
2012-01-27 |
2021-01-22 |
比奥马林技术公司 |
治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸
|